Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs Kingsoft Cloud Holdings Limited (KC) Price & Performance

Amphastar Pharmaceuticals IncTrade
Kingsoft Cloud Holdings LimitedTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs Kingsoft Cloud Holdings Limited — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.74 (market cap $826.08M), while Kingsoft Cloud Holdings Limited trades at $10.5 (market cap $3.25B). The key difference: Kingsoft Cloud Holdings Limited is far larger — about 3.9× Amphastar Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.

AMPHKC
Market Cap
$826.08M$3.25B
Sector
HealthTechnology
52-Week High
$30.81$18.21
52-Week Low
$16.87$8.58
Enterprise Value
$1.22B$3.56B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amphastar Pharmaceuticals Inc

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Kingsoft Cloud Holdings Limited

Kingsoft Cloud (KC) trades at $10.91, up 4.2% today, with a bullish technical signal and strong analyst support (70% buy ratings). Recent earnings beats and accelerating revenue growth, driven by AI cloud demand, highlight operational momentum, though profitability remains negative. The stock is near resistance at $11, with RSI indicating potential overbought conditions short-term.

The outlook is cautiously optimistic given AI-driven growth potential and positive sentiment, but risks include persistent losses, high capital expenditure, and competitive pressures. Upside depends on margin improvement from AI investments, making KC a speculative growth play with significant execution risk.

Returns comparison

Trailing returns across standard periods

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About Kingsoft Cloud Holdings Limited

Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.

Read more on KC